
A Winning Bid
Founded in 1998, Emergent BioSolutions has gone on to become a multinational biopharma company – despite working in some difficult therapeutic areas, including biodefense.

False
Founded in 1998, Emergent BioSolutions has gone on to become a multinational biopharma company – despite working in some difficult therapeutic areas, including biodefense.

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Jim Jackson is Chief Scientific Officer at Emergent BioSolutions.
False
False
April 11, 2025
2 min read
The 2025 Power List will be available soon!
April 7, 2025
4 min read
Celon Pharma CEO hopes their new compound could be a potential breakthrough for Parkinson’s patients.
April 2, 2025
2 min read
How fluid flow through the body can affect the ways in which antibiotics work.
March 27, 2025
2 min read
Thoughts on the US National Institutes of Health and its role in funding research for non-opioid therapeutics.
False
Affiliations:
Specialties:
Areas of Expertise: